President, British Pharmacological Society
UK drug funding framework needs an overhaul to ensure the right areas are being prioritisedSubscription
If the NHS is to get value for money from medicines, it needs to consider what the UK population values and where its priorities lie.
Respecting the decision of UK voters to leave the European Union (EU), it is crucial that British scientists maintain healthy and productive collaborations with our European colleagues, and continue to build the strongest science within the broader international community. The British Pharmacological Society is proud to be a global community at the heart of pharmacology: one-fifth of our membership is international, our journals have a global readership, and we represent scientists fro